Skip to main content
Premium Trial:

Request an Annual Quote

As Expected, Nasdaq Delists Tripos From Global Market; Will Now Look to OTC

NEW YORK (GenomeWeb News) — The Nasdaq Global Market has delisted Tripos’ common stock as of this morning, Tripos said today.
Tripos said the exchange notified the company on Tuesday it would be removed from the exchange for non-compliance with market rules concerning minimum market capitalization and shareholder’s equity.
Tripos said the delisting was expected due to the recent sale of its Discovery Research business, after which it had become a “public shell” and was no longer eligible for listing on the Nasdaq Global Market.
The company said it plans to ask for bids on the Over-the-Counter Bulletin Board, and that its stock will be available for quotation on the Pink Sheets electronic quotation service.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.